MSC Choc: Injecting allogenic stem cells to treat septic shock


04 Mars 2016

Partager sur facebook Partager sur twitter Partager sur linkedin Partager sur google+


Biology / Medical



An innovation that brings to you:

  • Cellular therapy.

How does it work?

This technique consists in isolating and characterizing a donor bone marrow stem cells to inject it to a patient experiencing the first stages of a septic shock (disproportionate answer of the immune system to an infection: 40 000 deaths in France).

These stem cells, apart from their regenerative capacity, exhibit an activity of local immunomodulation, of monocytic reprogramming, and of organ dysfunction attenuation.

What is it for?

  • Septic shock treatment by stem cells injection;
  • Cellular therapy.

Innovation availability: 

  • Patent licensing.

Target markets:

  • Hospital resuscitation;
  • Regenerative medicine.


Download the offer Download the offer